Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

NRS-Approved Features

NRS Approved Features
08/05/2024
A recent consensus statement addresses the need for standardized outcome measures in clinical trials involving patients with rosacea.
A recent consensus statement addresses the need for standardized outcome measures in clinical trials involving patients with rosacea.
A recent consensus statement...
08/05/2024
The Dermatologist
NRS Approved Features
05/03/2024
Riya Gandhi, MA, Associate Editor
For this year’s National Rosacea Awareness Month, Dr Hilary Baldwin sheds light on the crucial role of proper skin care in managing rosacea alongside medical therapies.
For this year’s National Rosacea Awareness Month, Dr Hilary Baldwin sheds light on the crucial role of proper skin care in managing rosacea alongside medical therapies.
For this year’s National Rosacea...
05/03/2024
The Dermatologist
NRS Approved Features
02/07/2024
National Rosacea Society staff
Recent research shines light on rosacea’s complex disease process and provides avenues for further investigation.
Recent research shines light on rosacea’s complex disease process and provides avenues for further investigation.
Recent research shines light on...
02/07/2024
The Dermatologist
NRS Approved Features
12/05/2023
Riya Gandhi, MA, Associate Editor
Better utilization of patient-reported outcomes in clinical trials, other clinical studies, and in our clinical practice is an opportunity to gather meaningful data on patients’ lived experiences.
Better utilization of patient-reported outcomes in clinical trials, other clinical studies, and in our clinical practice is an opportunity to gather meaningful data on patients’ lived experiences.
Better utilization of...
12/05/2023
The Dermatologist
NRS Approved Features
09/11/2023
Riya Gandhi, MA, Associate Editor
New National Rosacea Society resource seeks to empower patients with rosacea and enhance their quality of life.
New National Rosacea Society resource seeks to empower patients with rosacea and enhance their quality of life.
New National Rosacea Society...
09/11/2023
The Dermatologist
NRS Approved Features
05/08/2023
Jessica Garlewicz, Digital Managing Editor
To achieve optimal results, physicians and patients should work together to identify appropriate therapies and monitor their progress.
To achieve optimal results, physicians and patients should work together to identify appropriate therapies and monitor their progress.
To achieve optimal results,...
05/08/2023
The Dermatologist
NRS Approved Features
02/03/2023
Riya Gandhi, MA, Associate Editor
Since 1999, the National Rosacea Society has supported scientific studies investigating key areas of interest in rosacea, including inflammation, genetics, and ocular involvement.
Since 1999, the National Rosacea Society has supported scientific studies investigating key areas of interest in rosacea, including inflammation, genetics, and ocular involvement.
Since 1999, the National Rosacea...
02/03/2023
The Dermatologist
NRS Approved Features
12/07/2022
Riya Gandhi, MA, Associate Editor
We round up 3 important studies from this year to keep you up-to-date on the latest findings in rosacea.
We round up 3 important studies from this year to keep you up-to-date on the latest findings in rosacea.
We round up 3 important studies...
12/07/2022
The Dermatologist
NRS Approved Features
10/18/2022
Mary Erhard, National Rosacea Society
Persistent erythema is the most common and bothersome sign of rosacea, according to respondents. This highly visible phenotype may lead to serious invisible burdens.
Persistent erythema is the most common and bothersome sign of rosacea, according to respondents. This highly visible phenotype may lead to serious invisible burdens.
Persistent erythema is the most...
10/18/2022
The Dermatologist
NRS Approved Features
08/16/2022
Jessica Garlewicz, Associate Digital Editor
Up to 10% of the world’s population is affected by rosacea. Rhinophyma can be seen in patients with chronic rosacea, particularly men aged 50 years and older.
Up to 10% of the world’s population is affected by rosacea. Rhinophyma can be seen in patients with chronic rosacea, particularly men aged 50 years and older.
Up to 10% of the world’s...
08/16/2022
The Dermatologist

Advertisement

Advertisement

Advertisement